Stocktwits on MSN
TRVI stock slips after company plans parallel trials in lung disease — Stifel dismisses timeline concerns
While one of the two late-stage trials will be initiated in the second quarter, the second will be kickstarted in the second ...
Immunology startup Parallel Bio has released a model of the human immune system that is said to capture the way immunotherapies affect the body more accurately than animals. The so-called “Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results